Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/3/19 → 7/12/21 |
Funding
- Novo Nordisk Pharmaceuticals Inc: $50,041.00
Investigation of Efficacy and Safety of Semaglutide s.c. Once-Weekly Versus Placebo in Subjects with Aon-Alcoholic Steatohepatitis and Compensated Liver Cirrhosis
- Leyson, Christina (PI)